Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Kane Biotech Inc (KNBIF)

Kane Biotech Inc (KNBIF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Kane Biotech Announces $3,000,000 Private Placement Offering GlobeNewswire - Tue Dec 3, 7:30AM CST

KNE.VN : 0.100 (unch)
KNBIF : 0.0673 (-0.15%)
Kane Biotech Announces Third Quarter 2024 Financial Results GlobeNewswire - Thu Nov 28, 3:15PM CST

KNE.VN : 0.100 (unch)
KNBIF : 0.0673 (-0.15%)
Kane Biotech Announces Change in US Distribution Partner for revyve™ Antimicrobial Wound Gel GlobeNewswire - Wed Nov 27, 7:30AM CST

KNE.VN : 0.100 (unch)
KNBIF : 0.0673 (-0.15%)
Kane Biotech to Release Third Quarter 2024 Financial Results on November 28, 2024 GlobeNewswire - Thu Nov 21, 3:30PM CST

KNE.VN : 0.100 (unch)
KNBIF : 0.0673 (-0.15%)
Kane Biotech Announces Health Canada Approval of revyve™ Antimicrobial Wound Gel GlobeNewswire - Thu Nov 14, 12:10PM CST

KNE.VN : 0.100 (unch)
KNBIF : 0.0673 (-0.15%)
Kane Biotech Provides Investor Update Following FB Dermatology Acquisition Announcement GlobeNewswire - Thu Nov 14, 7:30AM CST

KNE.VN : 0.100 (unch)
KNBIF : 0.0673 (-0.15%)
Kane Biotech Announces Agreement to Acquire FB Dermatology GlobeNewswire - Tue Nov 12, 12:08PM CST

KNE.VN : 0.100 (unch)
KNBIF : 0.0673 (-0.15%)
Kane Biotech Announces Donation of revyve™ Antimicrobial Wound Gel to Ukraine GlobeNewswire - Wed Oct 23, 7:30AM CDT

KNE.VN : 0.100 (unch)
KNBIF : 0.0673 (-0.15%)
Kane Biotech Announces Exclusive Distribution Agreement With XSONX GlobeNewswire - Thu Oct 17, 7:30AM CDT

KNE.VN : 0.100 (unch)
KNBIF : 0.0673 (-0.15%)
Kane Biotech to Participate in a Multinational Corporate Collaboration Project GlobeNewswire - Thu Oct 3, 7:30AM CDT

KNE.VN : 0.100 (unch)
TOP : 1.3700 (-0.72%)
KNBIF : 0.0673 (-0.15%)

Barchart Exclusives

Is FedEx Stock a Buy, Sell, or Hold Ahead of Its Freight Spinoff? Barchart - Sat Dec 28, 10:00AM CST
Following FedEx’s move to spin off its freight division, does the stock present a compelling buy for investors, or is patience the wiser course? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot